faisal_raza

Mr. Faisal Raza (MS CPU, China)

Lecturer
PROFILE SUMMARY

Mr. Faisal Raza has completed MS. Degree in Pharmaceutics under Chinese Government Scholarship from China Pharmaceutical University (CPU), Nanjing, China, in 2019. He worked in different positions, including lecturer, research assistant and pharmacist. Mr. Faisal Raza has broad research interests in the areas of Pharmaceutics and drug delivery. His specific field of research focused on the design and synthesis of novel peptides and polymers for drug delivery, analyze therapeutic efficacy and toxicity studies in cancer mouse models, formulating and developing advanced drug delivery systems for poorly water-soluble anticancer drugs, developing of stimuli-responsive nanomedicine and biomimetic nanotechnology for cancer therapy. He authored/Co-authored 30+ research and review papers in well-reputed SCI journals, including Biomaterials, Advanced healthcare materials, Journal of materials chemistry B and Biomaterials Science with a total impact factor 150+.

QUALIFICATION
MS Pharmaceutics China Pharmaceutical University, Nanjing, Chinai 2019
Pharm.D. Pharmacy Quaid-i-Azam University, Islamabad, Pakistan 2016
TEACHING EXPERIENCE
Lecturer Capital University of Science and Technology (CUST), Islamabad Since – September 2021
Research Assistant State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China September 2016- July 2019
PROFESSIONAL EXPERIENCE
Internee Pharmacist Pakistan Institute of Medical Sciences (PIMS) Islamabad. July 2015 – September 2015
Hospital Pharmacist Mardan Medical Complex & Teaching Hospital, Mardan KPK July 2013 – September 2013
HONORS & AWARDS
1. Awarded full Chinese Government Scholarship for MS study (2016-2019)
2. Winner of Chinese Government outstanding international student award in the year of 2018.
3. Certificate of Outstanding Performance in 3rd Cultural week (2018) of China Pharmaceutical University.
4. Winner of Best International student 2017 certificate by international office CPU.
5. Certificate of Postgraduate course in Clinical Pharmacy, Faculty of Medicine & Dentistry, University of Alberta
6. Awarded second prize of poster in the 7th International Pharmacy Students academic forum on Nov 28, 2020 organized by School of international education, China Pharmaceutical University Nanjing, China.
7. Awarded third prize of poster in the 6th International Pharmacy Students academic forum on May 18 2019 organized by School of international education, China Pharmaceutical University Nanjing, China.
RESEARCH AREAS / INTERESTS
  1. Targeted drug delivery;
  2. Biomaterials;
  3. Cancer Nanomedicine;
  4. Cell membrane-derived Biomimetic Nanotechnology for cancer therapy;
  5. Tumor Microenvironment;
  6. Peptide synthesis;
  7. Exosome based drug delivery for cancer immunotherapy;
JOURNAL PUBLICATIONS
1. F. Raza, H. Zafar, S. Zhang, Z. Kamal, J. Su, W. Yuan and Q. Mingfeng, Recent “Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy”, Advanced healthcare materials, Vol. 10, no. 06, pp. 2002081, 2021.
2. F. Raza, Y. Zhu, L. Chen ,X. You, J. Zhang, A. U. Khan, M. W. Khan, M. Hasnat, H. Zafar, J. Wu and L. Ge, “Paclitaxel-loaded pH Responsive Hydrogel Based on Self-assembly Peptides for Tumor Targeting”, Biomaterials Science, vol. 7, no. 5, pp. 2023-2036, 2019.
3. F. Raza, H. Zafar, X. You, A. U. Khan, L. Ge and J. Wu, “Cancer Nanomedicine: Focus on recent developments and self-assembled peptide nanocarriers” Journal of Material Chemistry B, vol. 07, no. 48, pp. 7639-7655, 2019.
4. F. Raza, H. Zafar, Y. Zhu, Y. Ren, A. Ullah, A. U. Khan, X. He, H. Han, M. Aquib, K. O. B. Yiadom and L. Ge, “A Review on Recent Advances in Stabilizing Peptides/Proteins upon Fabrication in Hydrogels from Biodegradable Polymers”, Pharmaceutics, vol. 10, no. 01, pp. 16, 2018
5. F. Raza, L. Siyu, H. Zafar, Z. Kamal, B. Zheng, J. Su, and M. Qiu, “Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs”, Current Pharmaceutical Design, Under review, 2021.
6. H. Zafar, F. Raza, S. Ma, Y. Wei, J. Zhang and Q. Shen, “Recent advances in nanomedicine for ferroptosis-based cancer therapy”, Biomaterials Science, vol. 09, no. 15, pp. 5092-5115, 2021.
7. M. Aquib, H. Zhang, F. Raza, P. Banerjee, R. Bavi, S. Kesse, K. O. B. Yiadom, M. S. Filli, M. A. Farooq, B. Wang, “Delivery of repurposed disulfiram by aminated mesoporous silica nanoparticles for anticancer therapy” Journal of Molecular Liquids (In Press, Corrected Proof), pp. 117065, 2021.
8. X. Wang, M. Zheng, F. Raza, Y. Liu, Y. Wei, M. Qiu and J. Su, “Recent Developments in Mesoporous Silica Nanoparticles for Tumor Theranostic Applications” Current Pharmaceutical Design, Under review, 2021.
9. X. Wu, Y Li, F. Raza, X. Wang, S. Zhang, R. Rong, M. Qiu and J. Su, “Red Blood Cell Membrane-Camouflaged Tedizolid Phosphate-Loaded PLGA Nanoparticles for Bacterial-Infection Therapy” Pharmaceutics, vol. 13, no. 1, pp. 99, 2021.
10. K. A. Daddy J.C, M. Chen, F. Raza, Y. Xiao, Z. Su and Q. Ping, “Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia” Pharmaceutics, vol. 12, no. 02, pp. 192, 2020.
11. H. Zafar, M. H. Kiani, F. Raza, A. Rauf, I. Chaudhery, N. M. Ahmad, S. Akhtar and G. Shahnaz, “Design of enzyme decorated mucopermeating nanocarriers for eradication of H. pylori infection”, Journal of Nanoparticle Research, vol. 22, no. 01, pp. 1-21, 2020.
12. J. Yue, S. Zhang, B. Zheng, F. Raza, Z. Luo, Y. Li, X. Li, Y. Zhang, Q. Nie and M. Qiu, “Efficacy and mechanism of active fractions in fruit of Amomum villosum Lour. for Gastric Cancer”, Journal of Cancer, vol. 12, no. 20, pp. 5991-5998, 2021.
13. M. W. Khan, P. Zhao, A. U. Khan, F. Raza, S. M. Raza, M. Sarfraz, Y. Chen, M. Li, T. Yang, X. Ma and G. Xiang, “Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity” International Journal of Nanomedicine, vol. 14, no. 01, pp. 3753–3771, 2019.
14. Y. Zhu, X. You, K. Huang, F. Raza, X. Lu, Y. Chen, A. Dhinakar, Y. Zhang, Y. Kang, J Wu and L. Ge, “Effect of taste masking technology on fast dissolving oral film: dissolution rate and Bioavailability” Nanotechnology, vol. 29, no. 30, pp. 304001, 2018.
15. Z. Cheng, S. Liu, X. Wu, F. Raza, Y. Li, W. Yuan, M. Qiu and J. Su, “Autologous erythrocytes delivery of berberine hydrochloride with long-acting effect for hypolipidemia treatment” Drug Delivery, vol. 27, no. 01, pp. 283-291, 2020.
16. M. Hasnat, Z. Yuan, M. Naveed, A. U. Khan, F. Raza, D. Xu, A. Ullah, L. Sun, L. Zhang and Z. Jiang, “Drp1 associated mitochondrial dysfunction and mitochondrial autophagy: A novel mechanism in triptolide- induced hepatotoxicity”, Cell Biology and Toxicology, vol. 35, no. 03, pp. 267-280, 2018.
17. M. Hasnat, Y. ziqiao, A. Ullah, M. Naveed, F. Raza, M. M. F. A. Baig, A. U Khan, D. Xu, Y. Su, L. Sun, L. Zhang and Z. Jiang, “Mitochondria-dependent apoptosis in triptolide-induced hepatotoxicity is linked with Drp1 activation”, Toxicology Mechanism and method, vol. 30, no. 02, pp. 124-133, 2019 (SCI, IF: 2.987).
18. Y. Lian, X. Wang, P. Guo, Y. Li, F. Raza, J. Su and M. Qiu, “Erythrocyte membrane coated Arsenic trioxide loaded-sodium alginate nanoparticles for tumor therapy” Pharmaceutics, vol. 12, no. 01, pp. 21, 2020.
19. A. Ullah, G. Chen, A. Hussain, H. Khan, A. Abbas, Z. Zhou, M. Shafiq, S. Ahmad, U. Ali, M. Usman, F. Raza, A. Ahmed, Z. Qiu, M. Zheng and D. Liu, “Cyclam modified polyethyleneimine for simultaneous TGFβ siRNA delivery and CXCR4 inhibition for the treatment of CCl4-induced liver fibrosis” International Journal of Nanomedicine, vol. 16, no. 01, pp. 4451, 2021.
20. A. U. Khan, Z. Zhanwei, H. Weiming, G. Kun, M. W. Khan, F. Raza, M. Hasnat and S. Minjie, “CXCR4-Receptor Targeted Liposome for the treatment of Peritoneal Fibrosis”, Molecular Pharmaceutics, vol. 16, no. 06, pp. 2728-2741, 2019.
21. E. Xu, X. Wu, X. Zhang, K. Zul, F. Raza, J. Su and M. Qiu, “Study on the protection of dextran on erythrocytes during drug loading” Colloids and surfaces B: Biointerfaces, vol. 189, no. 01, pp. 110882, 2020 (SCI, IF: 5.268).
22. K. O. B. Yiadom, S. Kesse, Y. O. Damoh, M. S. Filli, M. Aquib, M. M. B. Joelle, M. A. Farooq, R. Mavlyanova, F. Raza, R. Bavi and B. Wang, “Carbon dots: Applications in Bioimaging and Theranostics, International Journal of Pharmaceutics, vol. 564, no. 01, pp. 308-317, 2019.
23. Y. Zhu, L. Wang, Y. Li, Z. Huang, S. Luo, Y. He, H. Han, F. Raza, J. Wu and L. Ge, “Injectable pH and redox dual responsive hydrogels based on self-assembled peptides for anti-tumor drug delivery”, Biomaterials Science, vol. 08, no. 19, pp. 5415-5426, 2020.
24. M. M. F. A. Baig, M. Sohail, A. A. Mirjat, M. Naveed, F. Majeed, F. Raza, M. A. Farooq, R. Mikrani, S. Khan, M. Abass, S. Ullah, M. Hasnat, W. Chunxia, G. J. Khan and M. T. Ansari, “PLLA alginate and the HPMC-EC hybrid coating over the 3D DNA nanocubes as compact nanoparticles for oral administration” Applied Nanoscience, vol. 09, no. 08, pp. 2105-2115, 2019.
25. M. M. F. A. Baig, W. F. Lai, A. Ahsan, M. Jabeen, M. A. Farooq, R. Mikrani, M. Abbas, M. Naveed, S. A. Kassim, F. Raza, A. A. Dar and M. T. Ansari, “Synthesis of Ligand Functionalized ErbB-3 Targeted Novel DNA Nano-Threads Loaded with the Low Dose of Doxorubicin for Efficient In Vitro Evaluation of the Resistant Anti-Cancer Activity” Pharmaceutical research, vol. 37, no. 04, pp. 1-12, 2020.
26. M. Aquib, M. A Farooq, P. Banerjee, F. Akhtar, M. S. Filli, K. O. B. Yiadom, S. Kesse, F. Raza, M. B. J. Maviah, R. Mavlyanova and B. Wang, “Targeted and stimuli-responsive mesoporous silica nanoparticles for drug delivery and theranostic use”, Journal of Biomedical Materials Research Part A, vol. 107, no. 12, pp. 2643-2666, 2019.
27. Y. Zhu, S. Luo, Y. Chen, F. Raza, H. Han, Z. Huang, Y. Li and L. Ge, “Preparation and studies of docetaxel proliposome”, Materials Express, vol. 09, no. 07, pp. 831-838, 2019.
28. M. S. Filli, A. A. Ibrahim, S. Kesse, M. Aquib, K. O. B. Yiadom, M. A. Farooq, F. Raza, Y. Zhang and W. Bo, “Synthetic Berberine derivatives as potential New Drugs”, Brazilian Journal of Pharmaceutical Sciences, vol. 01, no. 01, pp. 01, 2020 (SCI, IF: 1.321).
29. F. Hussain, B. Lu, X. Lan, J. Lyu, H. Huang, W. Zhou, S. Z. Shah, M. Shah, F. Raza, M. Saeed and M. Shuaib, “Determining Indigenous Microalgae Species in Malakand Water Bodies for Potential Use as a Biofuel Production Source”, Polish Journal of Environmental Studies, vol. 28, no. 2, pp. 01, 2019.
30. H. Khan, M. Fiaz, S. Khan, F. Hussain, S. Z. Shah, M. Shah, M. Shuaib, M. Saeed, F. Raza, M. K. Laghari, “Taxonomic study of fresh water Green Algae in relation to water quality of Tehsil Landikotal, Khyber Agency, Pakistan”, Pure and Applied Biology, vol. 06, no. 04, pp.1328-1334, 2017.
31. K. O. B. Yiadom, S. Kesse, M. S. Filli, M. Aquib, F. Raza, R. Mikrani, W. Bo, “Synergistic effect of solid dispersion and inclusion complex in Enhancing the solubility and stability of poor soluble Drugs” World journal of pharmaceutical Research, vol. 07, no. 17, pp.474-489, 2019
32. F. Raza, H. Zafar, L. Ge, N. ullah, A. U. Rehman, A. Ahmad, M. Usman, M. sohail, O. Ahmad, W. Nawaz, “Emerging trend in antibiotic resistance: Global views by Health Care Professionals” International Journal of Basic Medical Sciences and Pharmacy, vol. 07, no. 01, pp.01, 2017.

Other Members